Back
Viking Therapeutics Stock Price Chart
Sponsored
VKTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
VKTX
Viking Therapeutics
Last Price:
52.62
Seasonality Move:
50.47%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.82 | Buy |
20-day SMA: | 61.71 | Sell |
50-day SMA: | 63.78 | Sell |
200-day SMA: | 62.22 | Sell |
8-day EMA: | 53.58 | Sell |
20-day EMA: | 58.46 | Sell |
50-day EMA: | 61.44 | Sell |
200-day EMA: | 55.59 | Sell |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.14 | Sell |
Relative Strength Index (14 RSI): | 37.36 | Sell |
Chaikin Money Flow: | -474198 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.05 - 71.73) | Sell |
Bollinger Bands (100): | (54.01 - 67.19) | Sell |
Viking Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 52.59 while VKTX 8-day simple moving average is 51.82, which is a Buy signal.
- The stock price of VKTX is 52.59 while Viking Therapeutics 20-day SMA is 61.71, which makes it a Sell.
- Viking Therapeutics 50-day simple moving average is 63.78 while VKTX share price is 52.59, making it a Sell technically.
- VKTX stock price is 52.59 and Viking Therapeutics 200-day simple moving average is 62.22, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
38
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Sell
The current Viking Therapeutics [VKTX] share price is $52.59. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
5.86B
Price in USD:
52.59
Share Volume:
2.57M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
11.55
Sell
38
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 52.59 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 52.59 while VKTX 8-day exponential moving average is 53.58, which is a Sell signal.
- The stock price of VKTX is 52.59 while Viking Therapeutics 20-day EMA is 58.46, which makes it a Sell.
- Viking Therapeutics 50-day exponential moving average is 61.44 while VKTX share price is 52.59, making it a Sell technically.
- VKTX stock price is 52.59 and Viking Therapeutics 200-day simple moving average is 55.59, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is -4.14, suggesting Viking Therapeutics is a Sell
- Viking Therapeutics Relative Strength Index (RSI) is 37.36, which suggest Viking Therapeutics is oversold
- The Bollinger Bands (25) for Viking Therapeutics is (54.05 - 71.73), which suggest Viking Therapeutics is a Sell
- The Bollinger Bands (100) for Viking Therapeutics is (54.01 - 67.19), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.